- Home
- WISTEM2d
What WiSTEM²D is—and why it matters
Johnson & Johnson has invested in the STEM2D workforce to giving them the tools, resources and opportunities to succeed at work and at home since our founding more than 138 years ago.
Furthering that commitment, in 2015 we launched our WiSTEM2D initiative. WiSTEM2D stands for Winning in Science, Technology, Engineering, Math, Manufacturing and Design. We believe the STEM2D workforce can be catalysts for creating healthier people, healthier communities and a healthier world.
At J&J, we are dedicated to the values in Our Credo. We aim to inspire and empower all employees on their STEM2D journeys through access, engagement and skill development. Together, we believe STEM2D professionals are powerful catalysts for change in the world.
At J&J, we are dedicated to the values in Our Credo. We aim to inspire and empower all employees on their STEM2D journeys through access, engagement and skill development. Together, we believe STEM2D professionals are powerful catalysts for change in the world.
Supporting youth
Johnson & Johnson seeks to cultivate STEM2D interest at an early age to help youth grow and develop in these areas, preparing and positioning them to pursue higher education and careers in STEM2D. Through creative problem-solving and play, we aim to spark enchantment with STEM2D subjects in young people around the globe.
Supporting professionals
At Johnson & Johnson, we believe inclusive teams broaden viewpoints, allowing greater potential for new discoveries and innovations. To that end, we are championing the power of many perspectives through reimagined attraction and development of the world’s best STEM2D talent.
-
The WiSTEM2D program is continuing to blend our heart, science and ingenuity to profoundly impact health for humanity for the next generation of leaders. We do so by building partnerships to open new doors, creating inspiring moments to honor all in STEM2D, playing the part of role models and mentoring one another throughout the fundamental stages of our lives.
Kathy WengelExecutive Vice President & Chief Technical Operations & Risk Officer
More from Johnson & Johnson
Moving toward a more personalized approach to treating depression
The World Health Organization predicts that depression will be the leading cause of disability across the globe by 2030. Learn how Johnson & Johnson is on a mission to change that.
“Our goal is a solution for every bladder cancer patient”
Meet Christopher Cutie, M.D., the Johnson & Johnson scientist who’s helping change the treatment landscape for people with bladder cancer, the tenth most common cancer in the world.
How Johnson & Johnson is helping healthcare providers remotely monitor and support patient health
Expertise, innovation and insight are fueling the development of remote and AI-powered approaches to healthcare—potentially improving treatment decisions and evolving the way clinical trials are designed and managed.